Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04822649 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 2, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2024 to Dec 31, 2025v4
  2. Primary and study completion dates: Mar 2023 to Dec 2024
    • Study description expanded, about 1 word
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2021 to Apr 15, 2021
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The correlation of coronary microvascular function and body composition with cardiopulmonary exercise capacity will be assessed in patients with heart failure with preserved ejection fraction.
Trial Details
NCT Number NCT04822649
Lead Sponsor Korea University Anam Hospital
Conditions
(from sponsor)		 Heart Failure With Preserved Ejection Fraction (HFpEF)
Related terms Frailty
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov